3.960USD-6.60%Mkt Cap: 186.54M $P/E: —1d ago
Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that e…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap186.54M $
Enterprise Value122.61M $
Revenue (TTM)144.98M $
Gross Profit64.72M $
Net Income (TTM)-107.15M $
Revenue/Share3.243 USD
Last Price3.960 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees450
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.91
PEG—
EV/EBITDA-1.93
EV/Revenue0.85
P/S1.29
P/B0.66
EPS (TTM)-2.35
EPS (Forward)-1.36
52W Range
2.39525% of range8.770
52W High8.770 USD
52W Low2.395 USD
Profitability
Gross Margin46.67%
Oper. Margin-59.12%
EBITDA Margin-43.92%
Profit Margin-77.28%
ROE-36.23%
ROA-25.59%
Growth
Revenue Growth20.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-77.24M $
CapEx (TTM)2.61M $
FCF Margin-15.16%
FCF Yield-11.78%
Net Debt-63.93M $
Net Debt/EBITDA1.00
Balance Sheet
Debt/Equity0.13
Current Ratio3.72
Quick Ratio2.54
Book Value/Sh5.995 USD
Cash/Share2.107 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating3.0 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)4.333 USD
Upside (mean)+9.4%
Target Range4.000 USD – 5.000 USD
$4.000+9.4% to mean$5.000
# Analysts3
Ownership
Shares Out.47.11M
Float38.46M
Insiders6.30%
Institutions85.27%
Short Interest
Short Ratio3.4d
Short % Float10.35%
Short % Out.9.19%
Shares Short4.33M
Short (prev mo.)5.06M
Technical
SMA 503.355 (+18.0%)
SMA 2005.057 (-21.7%)
Beta1.04
S&P 52W Chg20.25%
Avg Vol (30d)980.07K
Avg Vol (10d)474.27K
Technical Indicators
RSI (14)54.0
MACD0.2048
MACD Signal0.2323
MACD Hist.-0.0275
BB Upper4.819 USD
BB Middle3.887 USD
BB Lower2.955 USD
BB Width47.97%
ATR (14)0.3520 USD
Vol Ratio (20d)0.94x